• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性对参与前列腺特异性抗原 (PSA) 筛查决策的看法:患者和公众参与调查制定。

Men's view on participation in decisions about prostate-specific antigen (PSA) screening: patient and public involvement in development of a survey.

机构信息

OPEN, Open Patient data Explorative Network, Department of Clinical Research, University of Southern Denmark, J. B. Winsløws Vej 9 a, 3 Floor, DK-5000, Odense C, Denmark.

Department of Psychology, University of Southern Denmark, Campusvej 55, DK-5230, Odense M, Denmark.

出版信息

BMC Med Inform Decis Mak. 2020 Apr 6;20(1):65. doi: 10.1186/s12911-020-1077-4.

DOI:10.1186/s12911-020-1077-4
PMID:32252729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7132968/
Abstract

BACKGROUND

Prostate-Specific Antigen (PSA) screening for early detection of prostate cancer (PCa) may prevent some cancer deaths, but also may miss some cancers or lead to unnecessary and potentially harmful treatment. Therefore, involving patients in decision-making about PSA screening is recommended. However, we know little about the attitude of men regarding participation in decisions about PSA screening and how to assess such attitudes. The purpose of this paper is to describe patient and public participation in the development of a national, web-based case vignette survey for studying men's view on participation in decision-making about PSA screening.

METHODS

The project group developed a first draft plan for the survey, its vignettes and choice of measurements. This included multiple vignette variants representing various levels of patient participation in decision-making about PSA screening with different outcomes. Additionally, it included questions on respondents' satisfaction with imagined courses of health care, their propensity to initiate a malpractice complaint, their own health care experiences, socio-demography, personality, and preferences for control regarding health care decision-making. Following feedback from a workshop with academic peers on the draft plan, a group of 30 adult men was engaged to help develop case vignette versions and questionnaire items by providing feedback on structure, comprehension, response patterns, and time required to complete the survey. Furthermore, a panel of three patients with PCa experience was assembled to assist development through a separate review-and-feedback process.

RESULTS

Based on reviews of survey drafts, the large group made further suggestions about construction of the survey (e.g. clarification and modification of case vignette versions, deletion of items and adjustment of wording, instructions to guide respondents, replacement of technical terms, and optimization of sequence of survey elements). The patient panel ensured fine-tuning of vignette versions and questionnaire items and helped review the internet version of the survey.

CONCLUSIONS

Patient and public involvement during various phases of the survey development helped modify and refine survey structure and content. The survey exemplifies a way to measure health care users' satisfaction with imagined courses of health care and wish to complain, taking into account their characteristics.

摘要

背景

前列腺特异性抗原(PSA)筛查可早期发现前列腺癌(PCa),从而预防部分癌症死亡,但也可能会漏诊一些癌症,或导致不必要的、潜在有害的治疗。因此,建议让患者参与 PSA 筛查决策。然而,我们对男性参与 PSA 筛查决策的态度以及如何评估这种态度知之甚少。本文旨在描述患者和公众参与制定全国性的、基于网络的病例情景调查,以研究男性对参与 PSA 筛查决策的看法。

方法

项目组制定了调查、病例情景和测量选择的初步草案计划。这包括多个病例情景变体,代表了不同水平的患者参与 PSA 筛查决策,以及不同的结果。此外,还包括对受访者对想象中的医疗保健过程的满意度、提起医疗事故投诉的倾向、自身的医疗保健经验、社会人口统计学、个性以及对医疗保健决策控制的偏好的问题。在学术同行研讨会上对草案计划提出反馈意见后,邀请了 30 名成年男性参与,帮助开发病例情景版本和问卷项目,对结构、理解、回应模式和完成调查所需的时间提供反馈。此外,还组建了一个由三名具有 PCa 经验的患者组成的小组,通过单独的审查和反馈过程协助开发。

结果

根据对调查草案的审查,大组对调查的构建提出了进一步的建议(例如,澄清和修改病例情景版本、删除项目和调整措辞、指导受访者的说明、替换技术术语以及优化调查要素的顺序)。患者小组对病例情景版本和问卷项目进行了微调,并帮助审查了调查的网络版本。

结论

在调查开发的各个阶段,患者和公众的参与有助于调整和完善调查的结构和内容。该调查体现了一种衡量医疗保健使用者对想象中的医疗保健过程的满意度和投诉意愿的方法,同时考虑了他们的特点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45af/7132968/06bdc7802c9e/12911_2020_1077_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45af/7132968/06bdc7802c9e/12911_2020_1077_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45af/7132968/06bdc7802c9e/12911_2020_1077_Fig1_HTML.jpg

相似文献

1
Men's view on participation in decisions about prostate-specific antigen (PSA) screening: patient and public involvement in development of a survey.男性对参与前列腺特异性抗原 (PSA) 筛查决策的看法:患者和公众参与调查制定。
BMC Med Inform Decis Mak. 2020 Apr 6;20(1):65. doi: 10.1186/s12911-020-1077-4.
2
Is greater patient involvement associated with higher satisfaction? Experimental evidence from a vignette survey.患者参与度越高是否会带来更高的满意度?来自情景调查的实验证据。
BMJ Qual Saf. 2022 Feb;31(2):86-93. doi: 10.1136/bmjqs-2020-012786. Epub 2021 Apr 22.
3
Does greater patient involvement in healthcare decision-making affect malpractice complaints? A large case vignette survey.患者更多地参与医疗决策是否会影响医疗事故投诉?一项大型病例案例调查。
PLoS One. 2021 Jul 2;16(7):e0254052. doi: 10.1371/journal.pone.0254052. eCollection 2021.
4
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.
5
Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.男性对前列腺癌筛查的偏好与权衡:一项离散选择实验
Health Expect. 2015 Dec;18(6):3123-35. doi: 10.1111/hex.12301. Epub 2014 Nov 10.
6
Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.前列腺癌的知情决策与前列腺特异性抗原(PSA)检测:一项随机对照试验,探讨简短患者决策辅助工具对男性关于检测的知识、态度及意愿的影响。
Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27.
7
Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.协商民主与癌症筛查同意书:关于社区陪审团对男性前列腺特异性抗原筛查知识及参与意愿影响的随机对照试验
BMJ Open. 2014 Dec 24;4(12):e005691. doi: 10.1136/bmjopen-2014-005691.
8
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌:患者是否在做出明智的决策?
J Fam Pract. 1999 Sep;48(9):682-8.
9
The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.患者偏好对前列腺癌筛查决策的重要性。前列腺患者结局研究团队。
J Gen Intern Med. 1996 Jun;11(6):342-9. doi: 10.1007/BF02600045.
10
Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.前列腺特异性抗原筛查试验和前列腺活检的预测因素。
Eur Urol. 2012 Oct;62(4):649-55. doi: 10.1016/j.eururo.2011.12.059. Epub 2012 Jan 10.

引用本文的文献

1
Implementing patient and public involvement (PPI) in eye research: reflections from developing a research study on Geographic Atrophy treatment acceptability.在眼科研究中实施患者和公众参与(PPI):关于开展一项地理萎缩治疗可接受性研究的思考
Res Involv Engagem. 2025 Aug 1;11(1):90. doi: 10.1186/s40900-025-00747-7.
2
Healthcare users' evaluations of general practice: a survey among Danish men aged 45-70 years.医疗保健用户对全科医疗的评价:一项针对45至70岁丹麦男性的调查。
BJGP Open. 2025 Jul 23;9(2). doi: 10.3399/BJGPO.2024.0153. Print 2025.
3
Shared decision-making endorses intention to follow through treatment or vaccination recommendations: a multi-method survey study among older adults.

本文引用的文献

1
Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer.我们是否应该更积极地让患者参与进来?多学科团队对转移性去势抵抗性前列腺癌老年患者共同决策的观点。
J Geriatr Oncol. 2019 Jul;10(4):653-658. doi: 10.1016/j.jgo.2018.12.003. Epub 2019 Jan 11.
2
User involvement in a Danish project on the empowerment of cancer patients - experiences and early recommendations for further practice.患者参与丹麦一项关于增强癌症患者权能的项目——经验及对进一步实践的早期建议。
Res Involv Engagem. 2018 Aug 13;4:26. doi: 10.1186/s40900-018-0105-3. eCollection 2018.
3
共同决策支持遵循治疗或疫苗接种建议的意向:一项针对老年人的多方法调查研究。
BMC Med Inform Decis Mak. 2024 Jul 23;24(1):202. doi: 10.1186/s12911-024-02611-2.
4
Associations between knowledge of health issues and health care satisfaction and propensity to complain: a cross-sectional survey of adult men in Denmark.健康问题知识与医疗满意度和投诉意愿之间的关联:丹麦成年男性的横断面调查。
BMJ Open. 2024 May 6;14(5):e076257. doi: 10.1136/bmjopen-2023-076257.
5
Complaint behaviour among healthcare users: self-reported complaint experience and complaint proneness in adult men.医疗保健使用者的投诉行为:成年男性的自我报告投诉经历和投诉倾向。
BMJ Open Qual. 2024 Feb 16;13(1):e002581. doi: 10.1136/bmjoq-2023-002581.
6
Patient and public involvement in cancer research: A scoping review.患者和公众参与癌症研究:范围综述。
Cancer Med. 2023 Jul;12(14):15530-15543. doi: 10.1002/cam4.6200. Epub 2023 Jun 16.
7
Personality characteristics associated with satisfaction with healthcare and the wish to complain.与对医疗保健的满意度和投诉意愿相关的人格特征。
BMC Health Serv Res. 2022 Nov 1;22(1):1305. doi: 10.1186/s12913-022-08688-7.
8
Does greater patient involvement in healthcare decision-making affect malpractice complaints? A large case vignette survey.患者更多地参与医疗决策是否会影响医疗事故投诉?一项大型病例案例调查。
PLoS One. 2021 Jul 2;16(7):e0254052. doi: 10.1371/journal.pone.0254052. eCollection 2021.
9
PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer.基于前列腺特异性抗原的生物标志物、影像学技术及联合检测以更好地诊断局限性前列腺癌。
Diagnostics (Basel). 2020 Oct 10;10(10):806. doi: 10.3390/diagnostics10100806.
10
Representativeness of personality and involvement preferences in a web-based survey on healthcare decision-making.在线医疗决策调查中的人格代表性和参与偏好。
BMC Health Serv Res. 2020 Sep 10;20(1):851. doi: 10.1186/s12913-020-05717-1.
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
前列腺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
4
How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity.离散选择实验在多大程度上能够预测健康选择?系统评价和元分析的外部有效性。
Eur J Health Econ. 2018 Nov;19(8):1053-1066. doi: 10.1007/s10198-018-0954-6. Epub 2018 Jan 29.
5
Twelve Lessons Learned for Effective Research Partnerships Between Patients, Caregivers, Clinicians, Academic Researchers, and Other Stakeholders.有效开展患者、照护者、临床医生、学术研究人员和其他利益攸关方之间研究合作的 12 点经验教训
J Gen Intern Med. 2018 Apr;33(4):558-562. doi: 10.1007/s11606-017-4269-6. Epub 2018 Jan 4.
6
A discrete choice experiment to assess cancer patients' preferences for when and how to make treatment decisions.一项离散选择实验,用于评估癌症患者对何时以及如何做出治疗决策的偏好。
Support Care Cancer. 2018 Apr;26(4):1215-1220. doi: 10.1007/s00520-017-3944-9. Epub 2017 Oct 31.
7
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.GRIPP2报告清单:用于改善患者和公众参与研究报告的工具。
Res Involv Engagem. 2017 Aug 2;3:13. doi: 10.1186/s40900-017-0062-2. eCollection 2017.
8
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-ESTRO-SIOG 前列腺癌诊治指南。第 1 部分:筛查、诊断及有治愈意图的局部治疗。
Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.
9
Re: Prostate-specific antigen-based prostate cancer screening: Past and future.关于:基于前列腺特异性抗原的前列腺癌筛查:过去与未来。
Int J Urol. 2016 Apr;23(4):348. doi: 10.1111/iju.13038. Epub 2016 Feb 2.
10
Doctors' risks of formal patient complaints and the challenge of predicting complaint behaviour.医生面临正式患者投诉的风险以及预测投诉行为的挑战。
BMJ Qual Saf. 2016 Sep 19;25:e2. doi: 10.1136/bmjqs-2015-005093.